Lol, no you didn't. You cannot answer it, which is yet another fundamental issue. If you don't know whether someone in Algeria was more likely to get HCQ than France - and CAN PUT A NUMBER TO THAT LIKELIHOOD - then the treatment groups are meaningless
-
This Tweet is unavailable.
-
-
Replying to @GidMK @c19analysis
And As I said in the thread, any treatment ~could~ be useful, but we now have numerous large trials demonstrating that HCQ is unlikely to be of any benefit
1 reply 0 retweets 1 like -
This Tweet is unavailable.
-
Replying to @c19analysis
No it doesn't. Collating self-selected studies on a website says nothing whatsoever about science. A numerically large number of bad studies is as meaningless as a numerically small number unfortunately
1 reply 0 retweets 1 like -
This Tweet is unavailable.
-
Replying to @c19analysis
Oh, lol, just realized what you've done. Studies that found no benefit are classified as 'inconclusive' based on a selective re-reading of the results. Quite funny, that
1 reply 0 retweets 1 like -
This Tweet is unavailable.
-
Replying to @c19analysis
No benefit for HCQ PEP: https://www.medrxiv.org/content/10.1101/2020.07.20.20157651v1 … The explanation on that website is a complete misunderstanding of the results, which were null and should be presented as negative in this context
1 reply 0 retweets 1 like -
This Tweet is unavailable.
The null hypothesis is that HCQ doesn't reduce COVID-19 infection, and appears very likely to be true based on these results
-
-
This Tweet is unavailable.
-
Replying to @c19analysis
You can ask what if about anything, but ultimately we only care about facts
1 reply 0 retweets 0 likes
End of conversation
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.